Back to comparisons

Comparison

Omega-3 (DHA/EPA) vs Fisetin

FieldOmega-3 (DHA/EPA)Fisetin
Categoryneuroprotectiveneuroprotective
Dose range1000–3000mg100–500mg
Half-life24h
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs52001700

The comparison in plain English

Auto-generated from data

Omega-3 (DHA/EPA) and Fisetin are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. Fisetin Flavonoid found in strawberries.

Bottom line

Omega-3 (DHA/EPA) (evidence A, safety 5/5) has a weaker evidence base than Fisetin (evidence B, safety 4/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Omega-3 (DHA/EPA) if

Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.

Choose Fisetin if

Fisetin is the better fit when your goal aligns with its mechanism (Senolytic activity, selectively induces apoptosis in senescent cells (cells that have stopped dividing but remain metabolically active and inflammatory)) and the dose range (100–500mg) suits your protocol. Half-life is –h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →